HRH3 and cognitive disorder: In this study, and on the two-trial object recognition test in mice, a promnesiant effect was observed regarding either scopolamine-induced or natural forgetting, signifying that the H3R antagonist/inverse agonist pitolisant was a valuable drug candidate for further development in wakefulness or memory deficits and other cognitive disorders (Ligneau et al., 2007).